MIRM

Mirum Pharmaceuticals Stock Analysis

AI Rating

Fair
  • Quality1/10
  • Growth↑ 8/10
  • Value↓ 1/10
Mirum Pharmaceuticals sales and earnings growth
MIRM Growth
Good
  • Revenue Y/Y↑ 54.74%
  • EPS Y/Y↑ 74.59%
  • FCF Y/Y↑ 488.01%
Mirum Pharmaceuticals gross and profit margin trends
MIRM Profitability
Neutral
  • Gross margin ↑ 80.80%
  • EPS margin↓ -4.50%
  • ROIC 5Y↓ -30.25%
Mirum Pharmaceuticals net debt vs free cash flow
MIRM Risk
Good
  • Debt / Equity↓ 1.0
  • Debt / FCF↓ 0.3
  • Interest coverage↓ -0.5

Mirum Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Good risk rating.

More Biotechnology stocks ↗